No headlines found.
No press releases found.
No news found.
The Fund is an actively managed exchange-traded fund ("ETF") that pursues its investment objective by seeking to provide exposure to companies involved in the development of pharmaceutical drugs and/or supplements that can be utilized to help individuals lose weight, maintain an ideal weight, and/or maintain body composition during weight loss ("GLP-1 & Weight Loss Drugs"). The Fund will focus its investments in the securities of companies that are the acknowledged leaders in the development of GLP-1 & Weight Loss Drugs, which it defines as those companies that have GLP-1 & Weight Loss Drugs currently undergoing Phase I, Phase II, and/or Phase III of U.S. Food & Drug Administration ("FDA") clinical trials and in securities of companies with GLP-1 & Weight Loss Drugs that have been approved by the FDA ("GLP-1 & Weight Loss Companies"). The Fund will also only invest in those companies with a minimum market capitalization of 100 million and an average daily trading volume of 500,000. The Adviser rebalances the weighting of the companies comprising the Fund's portfolio on at least a quarterly basis. The Fund may invest in U.S. and non-U.S. companies (including through investments in depositary receipts) and small-, mid- and large-capitalization issuers.
Roundhill Glp-1 & Weight Loss ETF trades on the NASDAQ stock market under the symbol OZEM.
As of January 27, 2026, OZEM stock price declined to $36.91 with 27,972 million shares trading.
OZEM has a beta of 0.68, meaning it tends to be less sensitive to market movements. OZEM has a correlation of 0.17 to the broad based SPY ETF.
OZEM has a market cap of $58.32 million. This is considered a Micro Cap stock.
OZEM has outperformed the market in the last year with a price return of +51.8% while the SPY ETF gained +15.6%. OZEM has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +35.4% and +3.3%, respectively, while the SPY returned +3.0% and 0.0%, respectively.
OZEM support price is $36.46 and resistance is $37.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OZEM shares will trade within this expected range on the day.
